OverviewSuggest Edit

TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options. The Company is focused on the commercialization of the Senhance Surgical Robotic System, a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology such as haptic feedback and eye sensing camera control. The Company also developed the SurgiBot™ System, a single-port, robotically enhanced laparoscopic surgical platform.

TypePublic
Founded2006
HQMorrisville, US
Websitetransenterix.com
Employee Ratings2.8

Latest Updates

Employees (est.) (Dec 2018)174(+47%)
Revenue (FY, 2018)$24.1 M(+239%)
Share Price (Jun 2019)$1.4 (+8%)

Key People/Management at TransEnterix

Todd M. Pope

Todd M. Pope

President & Chief Executive Officer
Joseph P. Slattery

Joseph P. Slattery

Executive Vice President & Chief Financial Officer
Anthony Fernando

Anthony Fernando

COO
Eric Smith

Eric Smith

Chief Commercial Officer
Wouter Donders

Wouter Donders

General Manager Europe
Paul Ziegler

Paul Ziegler

Vice President, Sales
Show more

TransEnterix Office Locations

TransEnterix has offices in Morrisville, Singapore, Milano, Lugano and in 1 other location
Morrisville, US (HQ)
635 Davis Dr #300
Milano, IT
Viale dell’Innovazione 3
Luxembourg, LU
33 rue du Puits Romain, Betrange
Singapore, SG
8 Shenton Way, #05-02 AXA Tower
Lugano, CH
1c Via Maggio
Show all (5)

TransEnterix Financials and Metrics

TransEnterix Revenue

TransEnterix's revenue was reported to be $24.10 m in FY, 2018
USD

Revenue (Q1, 2019)

2.2m

Gross profit (Q1, 2019)

(286.0k)

Gross profit margin (Q1, 2019), %

(13.1%)

Net income (Q1, 2019)

(22.5m)

EBIT (Q1, 2019)

(21.9m)

Market capitalization (10-Jun-2019)

299.9m

Closing stock price (10-Jun-2019)

1.4

Cash (31-Mar-2019)

25.5m
TransEnterix's current market capitalization is $299.9 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

1.4m401.0k1.5m7.1m24.1m

Revenue growth, %

(72%)(100%)

Cost of goods sold

4.8m1.1m1.1m6.7m16.2m

Gross profit

(3.4m)(694.0k)450.0k384.0k7.9m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Revenue

362.0k93.0k113.0k61.0k93.0k113.0k61.0k1.5m1.9m1.6m183.0k4.8m6.4m5.4m2.2m

Cost of goods sold

2.1m220.0k238.0k202.0k220.0k1.0m1.3m972.0k921.0k2.6m3.7m4.2m2.5m

Gross profit

(1.7m)(127.0k)(125.0k)(141.0k)(127.0k)435.0k612.0k612.0k(738.0k)2.2m2.7m1.2m(286.0k)

Gross profit Margin, %

(469%)(137%)(111%)(231%)(137%)30%31%39%(403%)46%42%22%(13%)
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

10.0m34.8m38.4m24.2m91.2m21.1m

Accounts Receivable

188.0k133.0k76.0k621.0k1.5m8.6m

Inventories

701.0k3.9m7.9m10.8m10.9m

Current Assets

17.8m35.7m49.1m38.0m113.0m101.6m
Quarterly
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(28.4m)(37.7m)(46.9m)(120.0m)(144.8m)(61.8m)

Depreciation and Amortization

1.5m1.3m3.4m8.9m10.3m13.3m

Inventories

731.0k701.0k(1.9m)(6.6m)(3.0m)(2.1m)

Accounts Payable

641.0k(36.0k)1.1m(356.0k)(531.0k)767.0k
USDY, 2019

Financial Leverage

1.5 x
Show all financial metrics

TransEnterix Operating Metrics

FY, 2016

Patent Applications

40

Patents Issued

19
Show all operating metrics

TransEnterix Online and Social Media Presence

Embed Graph

TransEnterix News and Updates

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating TransEnterix, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

NEW YORK, March 19, 2019 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of TransEnterix, Inc. (NYSE American: TRXC). If...

Expanding Scope on Robotic Surgical Systems Market 2019-2025: Global Companies like Intuitive Surgical, Transenterix, Johnson&Johnson, Hansen Medical, MEDTECH, Titan Medical, Microbot Medical

Robotic Surgical Systems Market from Qurate’s Repository provides detailed information, in depth analysis and forecast which is developed by team of experts and professionals. Posted via Industry Today. Follow us on Twitter @IndustryToday

Know Details about Global Robotic Gastrointestinal Surgery Market 2018-2023 Overview and Analysis, top key players - AVRA Surgical Robotics, Inc., Intuitive Surgical, Medtronic Inc, NovaTract Surgical Inc., Simbionix USA Corp, Titan Medical, TransEnterix

This market report is a thorough analysis of the existing situation and the anticipated condition for Robotic Gastrointestinal Surgery market. Investigation for gathering the content for this report is done in depth and meticulously. Present scenarios, past progress, global recognition and future pr…

Global Surgical Robotics Market: Focus on Products and Services, 2018-2025 - Key Players are Intuitive Surgical, Stryker, Mazor Robotics, MedRobotics, TransEnterix and Hansen Medical

DUBLIN, Nov. 12, 2018 /PRNewswire/ -- The "Global Surgical Robotics Market: Focus on Products and Services (Surgical Systems, Instruments & Accessories, and Services & Maintenance), Applications, End Users, and Competitive Landscape: Analysis and Forecast, 2018-2025" report has been added ..…

Robotic General Surgery 2018 Global Market Key Players – Accuray, Intuitive Surgical, Medrobotics Corporation, TransEnterix Surgical – Analysis and Forecast to 2021

WiseGuyRerports.com Presents “Global Robotic General Surgery Market 2017-2021” New Document to its Studies Database Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more

TransEnterix Blogs

TransEnterix to Showcase Digital Laparoscopy with the Senhance Surgical System at Society of American Gastrointestinal and Endoscopic Surgeons 2019 Annual Meeting

TransEnterix to Showcase Digital Laparoscopy with the Senhance Surgical System at Society of American Gastrointestinal and Endoscopic Surgeons 2019 Annual Meeting Content Import Thu, 03/28/2019 - 06:57 TransEnterix to Showcase Digital Laparoscopy with the Senhance Surgical System at Societ…

TransEnterix, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2018

TransEnterix, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2018 Content Import Tue, 02/26/2019 - 06:57 TransEnterix, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2018 February 26, 2019 at 6:55 AM EST …

TransEnterix Schedules Fourth Quarter and Fiscal Year 2018 Financial and Operating Results Conference Call for February 26, 2019

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Feb. 12, 2019-- TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release fourth quarter and fiscal year 2018 financial and operating results before the market opens on Tuesday, February 26, 2019 . Todd M.

TransEnterix Receives FDA 510(k) Clearance for Senhance Ultrasonic System

TransEnterix Receives FDA 510(k) Clearance for Senhance Ultrasonic System Content Import Tue, 01/15/2019 - 06:57 TransEnterix Receives FDA 510(k) Clearance for Senhance Ultrasonic System January 15, 2019 at 6:55 AM EST This release is a backfill from a News Wi…

TransEnterix to Present at the 37th Annual J. P. Morgan Healthcare Conference

TransEnterix to Present at the 37th Annual J. P. Morgan Healthcare Conference Content Import Thu, 12/20/2018 - 06:57 TransEnterix to Present at the 37th Annual J. P. Morgan Healthcare Conference December 20, 2018 at 6:55 AM EST This release is a backfill from …

TransEnterix Receives FDA 510(k) Clearance for 3mm Diameter Instruments

TransEnterix Receives FDA 510(k) Clearance for 3mm Diameter Instruments Content Import Thu, 10/11/2018 - 06:58 TransEnterix Receives FDA 510(k) Clearance for 3mm Diameter Instruments October 11, 2018 at 6:55 AM EDT This release is a backfill from a News Wire …
Show more

TransEnterix Frequently Asked Questions

  • When was TransEnterix founded?

    TransEnterix was founded in 2006.

  • Who are TransEnterix key executives?

    TransEnterix's key executives are Todd M. Pope, Joseph P. Slattery and Anthony Fernando.

  • How many employees does TransEnterix have?

    TransEnterix has 174 employees.

  • What is TransEnterix revenue?

    Latest TransEnterix annual revenue is $24.1 m.

  • What is TransEnterix revenue per employee?

    Latest TransEnterix revenue per employee is $138.5 k.

  • Who are TransEnterix competitors?

    Competitors of TransEnterix include OmniGuide, Bionik Laboratories and Open Bionics.

  • Where is TransEnterix headquarters?

    TransEnterix headquarters is located at 635 Davis Dr #300, Morrisville.

  • Where are TransEnterix offices?

    TransEnterix has offices in Morrisville, Singapore, Milano, Lugano and in 1 other location.

  • How many offices does TransEnterix have?

    TransEnterix has 5 offices.